Trial: 202006013

Phase II Trial of pTVG-HP DNA Vaccine with or without pTVG-AR DNA Vaccine and Pembrolizumab in Patients with Castration-Resistant, Metastatic Prostate Cancer

Phase

II

Principal Investigator

Pachynski, Russell

Disease Site

Prostate

Learn more about this study at: clinicaltrials.gov